Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
about
Merkel cell carcinoma in immunosuppressed patients.BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia.Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery.Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis.
P2860
Q34309887-49DB6922-B875-4186-8CF5-939F60067955Q35140116-91683A4F-0D9D-4101-AF48-4E8637BDCE52Q39043418-0CE5455A-D201-4B66-B4ED-6278E7D80D67Q39354550-38F2A83B-6AC7-4F8A-93C4-43470065EA73Q40257939-A5B799B4-3B77-4641-AAFC-3F0A77A2052BQ42507904-3C6269DE-1E3D-42C0-B783-FA970D297CDBQ47840579-3D59B5BE-F98C-40F9-8D8B-BF5A29C72E9E
P2860
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
@en
type
label
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
@en
prefLabel
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
@en
P2093
P2860
P356
P1476
Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
@en
P2093
Jerry D Brewer
Tait D Shanafelt
Thomas M Habermann
P2860
P304
P356
10.1111/IJD.12208
P577
2013-12-10T00:00:00Z